Article
Gilead Sciences takes back remdesivir distribution as demand drops
Rating:
0.0
Views:
111
Likes:
1
Library:
1
Gilead's remdesivir is one of only a few drugs to show benefits in COVID-19. After a somewhat chaotic initial rollout by the U.S. government and a drop in demand since, the company is now taking distribution of the antiviral into its own hands.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value